| Metric | Value (₹ Cr) | vs Q3 FY26 |
|---|---|---|
| Revenue | 370.45 | 0.9% |
| Total Income | 374.45 | 1.0% |
| Expenditure | 241.24 | 10.4% |
| PBT | 133.21 | 22.4% |
| Net Profit | 94.60 | 21.9% |
| OPM | 36.60% | 7.05pp |
| NPM | 25.26% | 4.75pp |
| EPS | 56.99 | 21.9% |
P&G Health FY26: Revenue from Operations ₹1407.97 Cr
26 May 2026 · 26 May, 5:12 pm
Summary
Procter & Gamble Health Limited announced a strong financial performance for the fourth quarter and the full financial year ended March 31, 2026. For Q4 FY26, the company recorded revenue from operations of ₹370.45 crore, representing a 19.12% year-on-year growth, alongside a net profit of ₹94.60 crore, which was up 54.63% from the corresponding quarter of the previous year. The net profit margin for the quarter stood at a robust 25.54%. For the entire financial year 2026, the company posted revenue from operations of ₹1,407.97 crore and a net profit of ₹326.91 crore. Additionally, the Board recommended a dividend of ₹45 per Equity Share for FY26.
Key Highlights
- 1
Procter & Gamble Health Limited reported revenue from operations of ₹370.45 crore for the quarter ended March 31, 2026, marking a 19.12% increase year-on-year.
- 2
The net profit for Q4 FY26 surged by 54.63% year-on-year to ₹94.60 crore.
- 3
For the full financial year ended March 31, 2026, revenue from operations stood at ₹1,407.97 crore.
- 4
The net profit for the full financial year 2026 reached ₹326.91 crore.
- 5
The company demonstrated strong profitability with a net profit margin of 25.54% for Q4 FY26.
- 6
The Board of Directors recommended a dividend of ₹45 per Equity Share (Nominal Value of ₹10/- each) for the financial year ended March 31, 2026.
Informational and educational content only. Not investment advice.